<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-157838" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Modified Blalock-Taussig-Thomas Shunt</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Alahmadi</surname>
            <given-names>Mohamed H.</given-names>
          </name>
          <aff>University of Health Sciences, Lahore</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Sanjeev</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bishop</surname>
            <given-names>Michael A.</given-names>
          </name>
          <aff>Mercy St. Vincent Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mohamed Alahmadi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sanjeev Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Bishop declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>22</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-157838.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Congenital heart disease (CHD) is the most common form of congenital disability, affecting approximately 8 out of every 1000 live births.<xref ref-type="bibr" rid="article-157838.r1">[1]</xref> In&#x000a0;many developing countries, CHD often goes undiagnosed until after birth or even later in life, sometimes presenting during childhood or adulthood. About 25% of infants born with a heart defect have critical CHD, necessitating surgical intervention or other procedures within the first year of life.<xref ref-type="bibr" rid="article-157838.r2">[2]</xref></p>
        <p>A commonly used palliative procedure for patients with CHD is the modified Blalock-Taussig-Thomas (mBTT) shunt. This procedure improves blood flow to the lungs, reduces cyanosis, promotes pulmonary artery growth, and helps maintain optimal cardiac preload, afterload, and coronary artery perfusion.<xref ref-type="bibr" rid="article-157838.r3">[3]</xref> The mBTT shunt is commonly performed in developing countries as a precursor to more definitive corrective surgery but has become less prevalent in developed nations. Advances in surgical techniques, technology, and the availability of specialized expertise have enabled early corrective surgeries in these regions.<xref ref-type="bibr" rid="article-157838.r4">[4]</xref></p>
        <p>Modern surgical decision-making relies on a blend of experience and careful consideration of competing performance goals. For example, the conduit must be sufficiently large to ensure adequate blood flow to the pulmonary vasculature for optimal oxygenation. However, excessive pulmonary blood flow can lead to complications such as pulmonary edema and heart failure. Additional risks associated with shunt hemodynamics include the potential for shunt stenosis or thrombosis, distortion of the pulmonary arteries, impaired coronary perfusion, and uneven growth of the pulmonary arteries.<xref ref-type="bibr" rid="article-157838.r5">[5]</xref></p>
        <p>
<bold>History</bold>
</p>
        <p>The mBTT shunt, a previous iteration of the classical Blalock-Taussig (BT) shunt, is a palliative surgical procedure designed to treat patients with cyanotic heart diseases that are characterized by decreased pulmonary artery flow. The first BT shunt was performed at the Johns Hopkins Hospital in 1944, resulting from the collaborative efforts of 3 individuals&#x02014;pediatric cardiologist Dr Helen Taussig, cardiac surgeon Dr Alfred Blalock, and laboratory assistant Mr Vivien Thomas.<xref ref-type="bibr" rid="article-157838.r6">[6]</xref>&#x000a0;The term "Blalock-Taussig shunt" was first used by de Leval when reporting on a series of patients who underwent the procedure between 1975 and 1979.<xref ref-type="bibr" rid="article-157838.r7">[7]</xref>&#x000a0;In 2003, a request was made to include the eponym "Thomas" to acknowledge the significant contributions of Mr Vivien Thomas to the success of the procedure.<xref ref-type="bibr" rid="article-157838.r8">[8]</xref></p>
        <p>The mBTT shunt is designed to provide adequate blood flow to the pulmonary artery, relieving cyanosis while avoiding pulmonary overcirculation. The classical BT shunt procedure involved a lateral thoracotomy, where the subclavian artery was divided and anastomosed to the pulmonary artery in an end-to-side manner. This original technique has undergone extensive modifications, evolving into the mBTT shunt, which uses an interposition polytetrafluoroethylene (PTFE) graft to create a systemic-to-pulmonary shunt without sacrificing the subclavian artery or any of the brachiocephalic tributaries.<xref ref-type="bibr" rid="article-157838.r9">[9]</xref>&#x000a0;In 1976, Gazzaniga&#x000a0;and colleagues&#x000a0;reported using a PTFE graft to construct an aortopulmonary shunt (see&#x000a0;<bold>Image.</bold>&#x000a0;Comparison of Classical Blalock-Taussig and Modified Blalock-Taussig-Thomas Shunts).<xref ref-type="bibr" rid="article-157838.r10">[10]</xref>&#x000a0;</p>
        <p>The mBTT shunt provides several advantages over the original iteration. By utilizing an interposition PTFE graft, the takedown procedure is simplified, blood flow to the ipsilateral upper limb is preserved, and shunt flow can be more precisely regulated by adjusting the diameter and length of the graft and selecting the appropriate anastomotic site.</p>
      </sec>
      <sec id="article-157838.s2" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>In the United States, CHD affects 1% of all deliveries, with about 25% of these cases classified as cyanotic congenital heart lesions.<xref ref-type="bibr" rid="article-157838.r11">[11]</xref><xref ref-type="bibr" rid="article-157838.r12">[12]</xref>&#x000a0;</p>
        <p>Common cyanotic&#x000a0;CHD anatomic lesions include, but are not limited to:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tetralogy of Fallot (TOF)</p>
          </list-item>
          <list-item>
            <p>Ebstein anomaly</p>
          </list-item>
          <list-item>
            <p>Hypoplastic left heart syndrome</p>
          </list-item>
          <list-item>
            <p>Total anomalous pulmonary venous return</p>
          </list-item>
          <list-item>
            <p>Transposition of great arteries</p>
          </list-item>
          <list-item>
            <p>Tricuspid atresia and other univentricular conditions</p>
          </list-item>
          <list-item>
            <p>Truncus arteriosus&#x000a0;</p>
          </list-item>
        </list>
        <p>Alternative physiological classification systems of cyanotic congenital heart lesions include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Right-to-left shunting</p>
          </list-item>
          <list-item>
            <p>Inadequate pulmonary blood flow</p>
          </list-item>
          <list-item>
            <p>Common mixing lesions</p>
          </list-item>
        </list>
        <p>The mBTT shunt offers temporary pulmonary arterial flow for cyanotic infants who are not yet candidates for definitive cardiac repair. Other aortopulmonary shunts, such as the Potts and Waterston shunts, are now rarely used due to high complication rates and challenges with removal during final repair (see&#x000a0;<bold>Image.</bold>&#x000a0;Systemic-to-Pulmonary Shunts). The Sano shunt, a right ventricle-to-pulmonary artery conduit, is used during stage I palliation for hypoplastic left heart syndrome and was first introduced by Norwood and colleagues in 1981.<xref ref-type="bibr" rid="article-157838.r13">[13]</xref></p>
      </sec>
      <sec id="article-157838.s3" sec-type="Indications">
        <title>Indications</title>
        <p>Palliative shunt procedures are less common today due to advancements in extracorporeal circulatory support, neonatal intensive care units, and improved surgical techniques that enable early corrective interventions. However, certain neonates with specific cyanotic congenital heart defects still require initial palliative surgery, as many of these conditions are not immediately treatable with corrective interventions. These defects often cannot be fully repaired initially, necessitating augmented pulmonary blood flow to support pulmonary artery development.</p>
        <p>Additionally, neonates with intracerebral bleeding or other contraindications to cardiopulmonary bypass may be suitable candidates for a palliative mBTT shunt. Severely premature neonates with cyanotic heart lesions may also receive an mBTT shunt until they are mature enough for definitive cardiac reconstructive surgery.</p>
        <p>Examples of cardiac anomalies that prevent complete repair but may be treated with the mBTT shunt include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypoplastic left heart syndrome: An mBTT shunt is placed as part of the Norwood procedure during stage 1 of the repair.<xref ref-type="bibr" rid="article-157838.r14">[14]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Congenitally corrected transposition of the great arteries: An mBTT shunt with pulmonary artery banding is the principal palliative treatment when this anomaly cannot be corrected.</p>
          </list-item>
          <list-item>
            <p>Coronary artery anomalies: Approximately 5% of&#x000a0;neonates with TOF demonstrate the left anterior descending coronary artery crossing the right ventricular outflow tract.<xref ref-type="bibr" rid="article-157838.r15">[15]</xref><xref ref-type="bibr" rid="article-157838.r16">[16]</xref><xref ref-type="bibr" rid="article-157838.r17">[17]</xref></p>
          </list-item>
        </list>
        <p>The mBTT shunt is utilized in various congenital cardiac lesions, particularly univentricular conditions where bidirectional Glenn and Fontan shunts cannot be established until neonatal pulmonary vascular resistance decreases.<xref ref-type="bibr" rid="article-157838.r18">[18]</xref>&#x000a0;Other&#x000a0;cardiac anomalies that necessitate augmented pulmonary blood flow and promote pulmonary artery development include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pulmonary atresia.</p>
          </list-item>
          <list-item>
            <p>Ebstein anomaly with functional pulmonary atresia.</p>
          </list-item>
          <list-item>
            <p>Inadequate pulmonary arteries.</p>
          </list-item>
          <list-item>
            <p>TOF, with palliative shunts for symptomatic, low-birth-weight neonates who cannot thrive on medical management.</p>
          </list-item>
          <list-item>
            <p>Ventricular septal defect with hypoplastic major aortopulmonary collateral arteries, where an mBTT shunt may be an option alongside unifocalization.</p>
          </list-item>
          <list-item>
            <p>Right ventricular outflow tract obstruction, including tricuspid stenosis or atresia, which was the primary indication for the BT shunt as described in the 1945 seminal article.<xref ref-type="bibr" rid="article-157838.r19">[19]</xref></p>
          </list-item>
        </list>
        <p>The modern approach to surgical decision-making is grounded in experience and requires balancing multiple, often conflicting, performance objectives. For example, while the conduit size must be adequate to ensure sufficient blood supply to the pulmonary vascular bed for proper oxygenation, an oversized conduit can cause excessive pulmonary blood flow, leading to complications like pulmonary edema and heart failure. Moreover, the hemodynamics of the shunt may result in additional complications, including shunt stenosis or thrombosis, distortion of the pulmonary arteries, compromised coronary perfusion, and uneven growth of the pulmonary arteries.</p>
      </sec>
      <sec id="article-157838.s4" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Pulmonary hypertension with elevated pulmonary vascular resistance is a relative contraindication for establishing an mBTT shunt.</p>
      </sec>
      <sec id="article-157838.s5" sec-type="Equipment">
        <title>Equipment</title>
        <p>Cardiopulmonary bypass must be available if cardioplegia is required during mBTT shunt placement, although not all cases will necessitate its use. If the surgical approach involves a median sternotomy, an electric sternotomy saw and stainless steel closure wires are essential. In contrast, a minimally invasive thoracotomy requires a Finochietto or Tuffier rib spreader, along with long-shafted pediatric instruments and standard cardiac surgery tools. PTFE grafts with predetermined diameters are the preferred conduits, as they ensure a precise fit for efficient anastomosis and optimal blood flow.</p>
      </sec>
      <sec id="article-157838.s6" sec-type="Personnel">
        <title>Personnel</title>
        <p>The personnel required for the placement of an mBTT shunt typically include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pediatric cardiothoracic surgeon</p>
          </list-item>
          <list-item>
            <p>Surgical first assistant</p>
          </list-item>
          <list-item>
            <p>Cardiac anesthesiologist</p>
          </list-item>
          <list-item>
            <p>Surgical technician or operating room nurse</p>
          </list-item>
          <list-item>
            <p>Circulating or operating room nurse</p>
          </list-item>
          <list-item>
            <p>Perfusionist, if cardiopulmonary bypass is utilized</p>
          </list-item>
        </list>
        <p>Each healthcare team member plays a vital role in ensuring the procedure's success and safety.</p>
      </sec>
      <sec id="article-157838.s7" sec-type="Preparation">
        <title>Preparation</title>
        <p>Preoperative evaluation of a cyanotic neonate involves a thorough prenatal and postnatal medical history, along with a complete physical examination. Congenital cardiac defects may occur in isolation or as part of a syndrome, making it essential to identify all associated anomalies. A transthoracic echocardiogram, interpreted by an experienced pediatric cardiologist, should include a detailed evaluation of the ascending aorta, aortic arch, and subclavian vessels. In some cases, coronary angiography or computed tomography angiography may be necessary to complete the assessment.</p>
        <p>When evaluating a cyanotic neonate, close attention should be given to any history of recurrent respiratory infections, which may signal abnormal pulmonary blood flow. Performing mBTT shunt placement on a neonate or infant with an active respiratory infection increases the risk of perioperative complications. Premature and term infants with a body weight of less than 3 kg are at heightened risk of perioperative complications and may require intraoperative and postoperative cardiopulmonary support.</p>
        <p>The diameter of the PTFE interposition graft should be determined preoperatively using the Hagen&#x02013;Poiseuille equation:</p>
        <p><italic toggle="yes">Q</italic> = &#x00394;<italic toggle="yes">p</italic>&#x003c0;<italic toggle="yes">d<sup>4</sup></italic>/8<italic toggle="yes">L&#x003bc;</italic></p>
        <p>where,</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Q</italic> = Volumetric flow rate</p>
          </list-item>
          <list-item>
            <p>&#x00394;<italic toggle="yes">p</italic> = Pressure difference</p>
          </list-item>
          <list-item>
            <p>&#x003c0; (pi) = 3.14159...</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">d</italic> = Diameter of the graft</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">L</italic> = Length of the graft</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">&#x003bc;</italic> = Blood viscosity</p>
          </list-item>
        </list>
        <p>A small change in shunt diameter can exponentially affect blood flow, whereas shunt length has a lesser impact. Neonates with a body weight of 2.5 to 4.0 kg typically receive adequate pulmonary blood flow with a PTFE conduit measuring 3.0 to 3.5 mm in diameter. For neonates with a body weight of less than 2.5 kg, a conduit smaller than 3.0 mm is recommended, while those with a body weight of more than 4.0 kg may benefit from a shunt with a 4.0 mm diameter.<xref ref-type="bibr" rid="article-157838.r20">[20]</xref></p>
      </sec>
      <sec id="article-157838.s8" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>
<bold>Surgical Technique for Modified Blalock-Taussig-Thomas Shunt Placement</bold>
</p>
        <p>The mBTT shunt procedure is typically performed without cardiopulmonary bypass in most centers. While the classical BT shunt was performed via a thoracotomy on the side of the aortic arch, the mBTT shunt is now routinely placed through a median sternotomy. This surgical approach offers several advantages, including the flexibility to place the shunt on either side of the chest, enhanced surgical exposure, and easier access to urgent cannulation and cardiopulmonary support if needed. Moreover, median sternotomy reduces the risk of intraoperative injury to the recurrent laryngeal nerve and lowers the likelihood of postoperative Horner syndrome.</p>
        <p>A median sternotomy also allows for the repair of concomitant congenital lesions, such as a patent ductus arteriosus. However, early use of this approach can hinder the development of collateral flow from the internal thoracic arteries, which may complicate and pose challenges for future cardiac interventional procedures.<xref ref-type="bibr" rid="article-157838.r21">[21]</xref></p>
        <p>Regardless of the surgical approach, many surgeons ligate the azygos vein early during the repair of complex lesions to simplify future shunt takedown procedures. mBTT shunt placement also necessitates a subtotal thyroidectomy. Additionally, a laryngoscopic examination during intubation is performed before making the surgical incision.</p>
        <p>A standard median sternotomy is performed with a skin incision slightly shorter than the length of the sternum. Mosquito forceps are used to detach the diaphragmatic attachments from the xiphoid process and the inferior sternum. After dividing the sternum, a subtotal thyroidectomy is performed on the side of the shunt placement, taking special care to avoid injury to the recurrent laryngeal nerve. The cervical extension of the thyroid may be preserved on the opposite side. An extensive thymectomy is conducted using electrocautery to excise thymic tissue from its capsule, particularly on the side planned for the shunt.</p>
        <p>The pericardium is incised longitudinally at the center, and traction sutures are placed to facilitate access to the right atrium. Early in the procedure, the right atrium is exposed, and a pursestring suture is secured in preparation for emergency cannulation or the insertion of an Intracath<sup>&#x000ae;</sup> to monitor right atrial pressure.</p>
        <p>The innominate artery is identified and dissected up to the subclavian-to-carotid artery bifurcation. The decision&#x000a0;to place the proximal anastomosis on either the innominate or subclavian artery depends on the surgeon's preference and anatomical feasibility, ensuring that no distortion occurs. Retracting the aorta facilitates access to the right pulmonary artery, which should be dissected from its attachment to the main pulmonary artery on one end to the level of the lung hilum on the other.</p>
        <p>The surrounding lymph nodes and lymphatics should be resected to ensure the PTFE conduit lies comfortably, eliminating any residual anastomotic tension at the end of the operation. The PTFE graft is beveled on the side intended for anastomosis with the subclavian artery, while the other end is directed toward the right pulmonary artery. Although the PTFE graft has proven to be a superior option, there has been renewed interest in using homografts from the femoral artery or saphenous vein.<xref ref-type="bibr" rid="article-157838.r22">[22]</xref>&#x000a0;</p>
        <p>The proximal anastomosis is performed using an atraumatic C-shaped vascular clamp applied to the innominate or subclavian artery. A longitudinal incision is made, and the beveled end of the PTFE graft is sutured to the arteriotomy with monofilament nonabsorbable sutures, such as 6-0, 7-0, or 8-0 polypropylene, in a continuous manner. After completing the proximal anastomosis, heparinization is administered to minimize clot formation within the graft. The graft is cross-clamped, and the C-clamp is released to assess the proximal anastomosis for leaks and to ensure optimal graft position and length. Once confirmed, the distal anastomosis is performed on the right pulmonary artery.</p>
        <p>The pulmonary artery is clamped with an atraumatic C-clamp, and an arteriotomy is made along the clamped area to prepare for anastomosis with the distal end of the PTFE conduit. Many surgeons prefer to test the patient's oxygen saturation and hemodynamics by temporarily clamping the pulmonary artery before creating the arteriotomy. The distal anastomosis is performed using the same materials and technique as the proximal connection to the innominate artery. Careful attention is required to ensure proper orientation of the distal anastomosis when the clamps are released. The mBTT shunt is then inspected at both ends for leakage and checked for fibrinous clots within the graft.</p>
        <p>In patients who are duct-dependent, the patent ductus arteriosus should be ligated only after confirming the patency of the newly created systemic-to-pulmonary shunt. Shunt patency and flow can be evaluated using echocardiography or manual testing. Manual testing of the shunt involves clamping and releasing it while palpating for a thrill in the distal pulmonary artery and monitoring hemodynamic changes. A spontaneous rise in systemic oxygen saturation, detected via photoplethysmography, serves as a reliable indicator of a functional shunt.</p>
        <p>Reversal of heparinization is not essential. Standard practices include routine chest closure with mediastinal drains, placement of atrioventricular pacing leads, and sternal approximation using stainless steel wires. Most patients tolerate the operation well, with minimal need for inotropic support.&#x000a0;Upon completion of the procedure, patients require intensive care for at least 1 week, with some potentially needing postoperative extracorporeal membrane oxygenation.</p>
        <p>
<bold>Surgical Technique for Modified Blalock-Taussig-Thomas Shunt Takedown</bold>
</p>
        <p>The takedown of an mBTT shunt is an integral part of any intracardiac repair. Shunt takedown halts the mixing of systemic and pulmonary blood, preventing the superior tenting of the pulmonary artery as the child grows. Tenting has been recognized as a significant contributor to unbalanced pulmonary blood flow between the lungs.</p>
        <p>Previous operative notes must be reviewed before the takedown procedure. Preoperative evaluation should include echocardiography, with angiography performed if needed. Following a median sternotomy, comprehensive dissection is often required to identify and mobilize the right pulmonary artery, which may be encased in a thick fibrous peel.</p>
        <p>The cardiopulmonary bypass should not be established until the&#x000a0;surgeon has full control of the systemic-to-pulmonary shunt, especially in patients with duct-dependent physiology. Once the cardiopulmonary bypass flow is&#x000a0;initiated, the shunt&#x000a0;may be ligated proximally and distally using hemostatic clips. The surgeon must ensure the PTFE conduit is completely disconnected to prevent arterial tenting and imbalanced pulmonary blood flow.&#x000a0;</p>
        <p>Transcatheter occlusion of the mBTT shunt has been reported in hybrid repair settings and isolated cases. However, the risk of embolization from a clot or device is higher with the transcatheter approach than with surgical takedown.<xref ref-type="bibr" rid="article-157838.r23">[23]</xref></p>
      </sec>
      <sec id="article-157838.s9" sec-type="Complications">
        <title>Complications</title>
        <p>Despite advancements in surgical techniques, enhanced intensive care services, and cutting-edge surgical materials, systemic-to-pulmonary artery shunt operations continue to exhibit high in-hospital mortality rates, ranging from 2.3% to 16%.<xref ref-type="bibr" rid="article-157838.r24">[24]</xref>&#x000a0;However, only 2 factors&#x02014;body weight less than 4.25 kg and the timing of surgery (elective versus emergency)&#x02014;have been found to significantly affect mortality following a BT shunt procedure. Specifically, a body weight of less than 4.25 kg increases the mortality risk by 20.8 times, while emergency surgery raises the risk by 3.5 times. Notably, no studies have specifically investigated the correlation between the timing of surgery and mortality risk.</p>
        <p>The primary disadvantage of using PTFE as the conduit for the mBTT shunt is the sporadic occurrence of serous leakage through the synthetic polymer fabric. This leakage can lead to localized seroma formation and an extended requirement for tube thoracostomy.</p>
        <p>The most significant complication of the mBTT shunt procedure is pulmonary overcirculation in the early postoperative period. This condition may arise from high systemic vascular resistance, low pulmonary vascular resistance, or an inappropriately large systemic-to-pulmonary shunting. Pulmonary overcirculation can result in systemic hypotension, ventricular overload, pulmonary edema, and acidosis. If left uncorrected, it may lead to cardiac arrest and death. The imbalance in blood shunting from the systemic to pulmonary circulation heightens the risk of heart failure and compromises systemic perfusion of vital organs, potentially leading to intestinal ischemia and necrotizing enterocolitis.&#x000a0;</p>
        <p>Contrarily, shunt distortion or thrombosis can result in pulmonary hypoperfusion, hypoxia, and cyanosis. To prevent thrombosis, prophylactic heparinization is initiated in the immediate postoperative period at a rate of 10 units/kg/h, with adjustments made based on subsequent coagulation profile results. Additionally, aspirin is started at a dosage of 3 to 5 mg/kg once daily, not exceeding a maximum of 75 mg/d, and is continued for the patient's lifetime.</p>
        <p>Although technically demanding and associated with a risk of significant complications, transcatheter intervention can serve as a viable rescue approach for reestablishing patency in the event of thrombotic blockage in an mBTT shunt.<xref ref-type="bibr" rid="article-157838.r25">[25]</xref>&#x000a0;Continuous, vigilant monitoring of hemodynamics during early postoperative management is crucial, accompanied by a low threshold for surgical reintervention when necessary.</p>
        <p>The functionality of an mBTT shunt can be clinically assessed through palpation and auscultation. A palpable thrill on the side of the shunt that radiates to the infraclavicular region, which was not present preoperatively, is a reassuring sign of shunt functionality and can be confirmed by auscultation over the area. A continuous murmur, best heard in the same subclavicular region, indicates that the systemic-to-pulmonary shunt functions effectively. Transthoracic echocardiography may be used to quantify shunted blood flow, while computed tomography angiography can provide a conclusive evaluation of shunt blood flow.</p>
      </sec>
      <sec id="article-157838.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>In a large retrospective study spanning 6 decades of research at the Johns Hopkins Hospital, Williams et al reported an overall decline in the use of the mBTT shunt.<xref ref-type="bibr" rid="article-157838.r18">[18]</xref> However, However, they observed a relative increase in its application for treating univentricular heart lesions. Notably, over 75% of the shunts analyzed in this study were classical BT shunts, which limits the applicability of the findings to the mBTT shunt.&#x000a0;The mBTT shunt is also considered safer than the Potts or Waterston shunt.<xref ref-type="bibr" rid="article-157838.r26">[26]</xref></p>
        <p>The Single Ventricle Reconstruction trial revealed that patients who underwent the Norwood procedure with right ventricle-to-pulmonary artery shunts had higher survival rates at 12 months without the need for cardiac transplantation compared to those receiving mBTT shunt placement. However, long-term survival rates for both groups were similar, and patients in the Norwood procedure group experienced a significant decline in overall right ventricular function.<xref ref-type="bibr" rid="article-157838.r27">[27]</xref>&#x000a0;At&#x000a0;6 years, there were no significant differences between the 2 groups in the risks of death, transplant, or catheter-based interventions.<xref ref-type="bibr" rid="article-157838.r28">[28]</xref><xref ref-type="bibr" rid="article-157838.r29">[29]</xref>&#x000a0;Another study revealed that patients with the mBTT shunt experienced a greater decline in weight-for-age z score compared to those with a Sano shunt.<xref ref-type="bibr" rid="article-157838.r30">[30]</xref></p>
        <p>When comparing the mBTT shunt with newer, less invasive, and more cost-effective&#x000a0;palliative techniques, such as ductal stenting, McMullan et al reported a higher percentage of procedure-related complications and distal branch pulmonary artery stenosis in the mBTT group, while freedom from intervention was similar in both groups.<xref ref-type="bibr" rid="article-157838.r31">[31]</xref>&#x000a0;Right&#x000a0;ventricular outflow tract stenting is another less-invasive palliative option that has demonstrated greater safety while being equally effective as the mBTT shunt in neonates with complex&#x000a0;TOF lesions.<xref ref-type="bibr" rid="article-157838.r32">[32]</xref>&#x000a0;</p>
        <p>The classical BT&#x000a0;shunt procedure, known as "the blue baby operation" in the 1940s, gained international fame and has saved the lives of millions of children worldwide. However, palliative procedures in congenital cardiac surgery are increasingly falling out of favor in contemporary clinical practice. The focus has shifted from palliating cardiac lesions to prioritizing the avoidance of complications associated with these interventions.</p>
      </sec>
      <sec id="article-157838.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Modern prenatal care enables the in-utero diagnosis of many congenital cardiac lesions. Neonates requiring surgical repair for complex cardiac conditions benefit from delivery at a tertiary cardiac center when possible. Effective communication and collaborative planning among healthcare specialists, including obstetricians, maternal-fetal medicine specialists, neonatal intensive care teams, pediatric cardiologists, and pediatric cardiothoracic surgeons, during the antenatal period ensures well-coordinated care while the patient is still a fetus. These prearranged plans can then be implemented at delivery, ideally in a controlled environment, thereby optimizing outcomes.</p>
        <p>All congenital abnormalities can be evaluated once the neonate is stabilized. Neonatal intensive care clinical staff and pharmacists have&#x000a0;integral roles in caring for neonates with cyanosis&#x000a0;from complex cardiac lesions. Additionally, family counselors and palliative care teams&#x000a0;within many neonatal intensive care units provide necessary support to families navigating the&#x000a0;complexities of the care system.</p>
        <p>The decision to perform a palliative cardiac procedure requiring intraoperative and postoperative cardiopulmonary support involves the expertise of multiple interprofessional team members, including surgeons, anesthesiologists, perfusionists, cardiologists, pediatricians, echocardiographers, dietitians, nurses, and pharmacists. Care coordinators play a vital role in facilitating communication among these professionals to optimize outcomes for patients undergoing mBTT shunt placement.</p>
      </sec>
      <sec id="article-157838.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=157838&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=157838">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/157838/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=157838">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-157838.s13">
        <fig id="article-157838.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Comparison of Classical Blalock-Taussig and Modified Blalock-Taussig-Thomas Shunts. The image on the left illustrates the classical aortopulmonary Blalock-Taussig shunt, which uses a divided subclavian artery as the shunt conduit. In contrast, the image on the right depicts the modified Blalock-Taussig-Thomas shunt, which utilizes a polytetrafluoroethylene (PTFE) graft as the shunt conduit. Contributed by MH Alahmadi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Classical__vs__modified__BTT__Shunt" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-157838.s14">
        <fig id="article-157838.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Systemic-Pumonary Shunts. This illustration demonstrates the differences among various systemic-pulmonary shunts, including the classical Blalock-Taussig (BT), modified Blalock-Taussig-Thomas (BTT), internal mammary artery to pulmonary artery (PA), Davidson, Waterston-Cooley, and Potts shunts. Contributed by P Rajiah, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Systemic-Pumonary__Shunts" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-157838.s15">
        <title>References</title>
        <ref id="article-157838.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sasikumar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hermuzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Chaturvedi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hickey</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Honjo</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Van Arsdell</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Caldarone</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of Blalock-Taussig shunts in current era: A single center experience.</article-title>
            <source>Congenit Heart Dis</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>12</volume>
            <issue>6</issue>
            <fpage>808</fpage>
            <page-range>808-814</page-range>
            <pub-id pub-id-type="pmid">28736841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jonas</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Congenital heart surgery in developing countries.</article-title>
            <source>Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu</source>
            <year>2008</year>
            <fpage>3</fpage>
            <page-range>3-6</page-range>
            <pub-id pub-id-type="pmid">18396218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amelia</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Advani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pulungan</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Djer</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Hegar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Prawira</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sukardi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Predicting Factors for Mortality in Patients After the Modified Blalock-Taussig Shunt Procedure in Developing Countries: A Retrospective Study.</article-title>
            <source>Int J Gen Med</source>
            <year>2023</year>
            <volume>16</volume>
            <fpage>5291</fpage>
            <page-range>5291-5300</page-range>
            <pub-id pub-id-type="pmid">38021062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rana</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Shamim</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Blalock-Taussig shunt: experience from the developing world.</article-title>
            <source>Heart Lung Circ</source>
            <year>2002</year>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>152</fpage>
            <page-range>152-6</page-range>
            <pub-id pub-id-type="pmid">16352089</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piskin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Altin</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Yildiz</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bakir</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pekkan</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Hemodynamics of patient-specific aorta-pulmonary shunt configurations.</article-title>
            <source>J Biomech</source>
            <year>2017</year>
            <month>Jan</month>
            <day>04</day>
            <volume>50</volume>
            <fpage>166</fpage>
            <page-range>166-171</page-range>
            <pub-id pub-id-type="pmid">27866675</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mainwaring</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Mainwaring</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The retirement years of Doctor Helen B. Taussig: an intersection of art and medicine.</article-title>
            <source>Cardiol Young</source>
            <year>2024</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>334</fpage>
            <page-range>334-347</page-range>
            <pub-id pub-id-type="pmid">37427599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Leval</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>McKay</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stark</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Macartney</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>1981</year>
            <month>Jan</month>
            <volume>81</volume>
            <issue>1</issue>
            <fpage>112</fpage>
            <page-range>112-9</page-range>
            <pub-id pub-id-type="pmid">6450303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brogan</surname>
                <given-names>TV</given-names>
              </name>
              <name>
                <surname>Alfieris</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Has the time come to rename the Blalock-Taussig shunt?</article-title>
            <source>Pediatr Crit Care Med</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>450</fpage>
            <page-range>450-3</page-range>
            <pub-id pub-id-type="pmid">14525641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yuan</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Shinfeld</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Raanani</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>The Blalock-Taussig shunt.</article-title>
            <source>J Card Surg</source>
            <year>2009</year>
            <season>Mar-Apr</season>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>101</fpage>
            <page-range>101-8</page-range>
            <pub-id pub-id-type="pmid">19040408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elliott</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Gazzaniga</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Haiduc</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Use of expanded polytetrafluoroethylene grafts for vascular access in hemodialysis: laboratory and clinical evaluation.</article-title>
            <source>Am Surg</source>
            <year>1977</year>
            <month>Jul</month>
            <volume>43</volume>
            <issue>7</issue>
            <fpage>455</fpage>
            <page-range>455-9</page-range>
            <pub-id pub-id-type="pmid">879604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoffman</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The incidence of congenital heart disease.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2002</year>
            <month>Jun</month>
            <day>19</day>
            <volume>39</volume>
            <issue>12</issue>
            <fpage>1890</fpage>
            <page-range>1890-900</page-range>
            <pub-id pub-id-type="pmid">12084585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Linde</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Konings</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Slager</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Witsenburg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Helbing</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Takkenberg</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Roos-Hesselink</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2011</year>
            <month>Nov</month>
            <day>15</day>
            <volume>58</volume>
            <issue>21</issue>
            <fpage>2241</fpage>
            <page-range>2241-7</page-range>
            <pub-id pub-id-type="pmid">22078432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piber</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ono</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Palm</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kido</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Burri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>R&#x000f6;hlig</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Strbad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cleuziou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lemmer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dilber</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Klawonn</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ewert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hager</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>H&#x000f6;rer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Influence of Shunt Type on Survival and Right Heart Function after the Norwood Procedure for Aortic Atresia.</article-title>
            <source>Semin Thorac Cardiovasc Surg</source>
            <year>2022</year>
            <season>Winter</season>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>1300</fpage>
            <page-range>1300-1310</page-range>
            <pub-id pub-id-type="pmid">34838954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldberg</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Gaynor</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Mahle</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Ravishankar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Frommelt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ilardi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bellinger</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Paridon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Minich</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Afton</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lamberti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Trachtenberg</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Gongwer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Atz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Chowdhury</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cnota</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Detterich</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Frommelt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Ohye</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Pizarro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Walters</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Newburger</surname>
                <given-names>JW</given-names>
              </name>
              <collab>Pediatric Heart Network Investigators</collab>
            </person-group>
            <article-title>The pediatric heart network's study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): Design and adaptations.</article-title>
            <source>Am Heart J</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>254</volume>
            <fpage>216</fpage>
            <page-range>216-227</page-range>
            <pub-id pub-id-type="pmid">36115392</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hurwitz</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Girod</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Caldwell</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Tetralogy of Fallot with abnormal coronary artery: 1967 to 1977.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>1980</year>
            <month>Jul</month>
            <volume>80</volume>
            <issue>1</issue>
            <fpage>129</fpage>
            <page-range>129-34</page-range>
            <pub-id pub-id-type="pmid">7382526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Need</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>del Nido</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Geva</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Coronary echocardiography in tetralogy of fallot: diagnostic accuracy, resource utilization and surgical implications over 13 years.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>1371</fpage>
            <page-range>1371-7</page-range>
            <pub-id pub-id-type="pmid">11028497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fellows</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Freed</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Keane</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Praagh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bernhard</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Castaneda</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Results of routine preoperative coronary angiography in tetralogy of Fallot.</article-title>
            <source>Circulation</source>
            <year>1975</year>
            <month>Mar</month>
            <volume>51</volume>
            <issue>3</issue>
            <fpage>561</fpage>
            <page-range>561-6</page-range>
            <pub-id pub-id-type="pmid">1139765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bansal</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Nwakanma</surname>
                <given-names>LU</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Seth</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Alejo</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Gott</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Vricella</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Two thousand Blalock-Taussig shunts: a six-decade experience.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>84</volume>
            <issue>6</issue>
            <fpage>2070</fpage>
            <page-range>2070-5; discussion 2070-5</page-range>
            <pub-id pub-id-type="pmid">18036938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blalock</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Taussig</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <article-title>Landmark article May 19, 1945: The surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. By Alfred Blalock and Helen B. Taussig.</article-title>
            <source>JAMA</source>
            <year>1984</year>
            <month>Apr</month>
            <day>27</day>
            <volume>251</volume>
            <issue>16</issue>
            <fpage>2123</fpage>
            <page-range>2123-38</page-range>
            <pub-id pub-id-type="pmid">6368878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bove</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Migliavacca</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>de Leval</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Balossino</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pennati</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Khambadkone</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hsia</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Dubini</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Use of mathematic modeling to compare and predict hemodynamic effects of the modified Blalock-Taussig and right ventricle-pulmonary artery shunts for hypoplastic left heart syndrome.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>136</volume>
            <issue>2</issue>
            <fpage>312</fpage>
            <page-range>312-320.e2</page-range>
            <pub-id pub-id-type="pmid">18692636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chandrasekaran</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mathew</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dharan</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Karunakaran</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kapilamoorthy</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title>Sternotomy after classic Blalock-Taussig shunt: a unique challenge.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>98</volume>
            <issue>3</issue>
            <fpage>1114</fpage>
            <pub-id pub-id-type="pmid">25193204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaur</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bhurtel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bielefeld</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Morales</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Durham</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Cryopreserved Saphenous Vein Compared With PTFE Graft for Use as Modified Blalock-Taussig or Central Shunt in Cyanotic Congenital Heart Disease.</article-title>
            <source>World J Pediatr Congenit Heart Surg</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>509</fpage>
            <page-range>509-512</page-range>
            <pub-id pub-id-type="pmid">30157727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baspinar</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Sahin</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Sulu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gokaslan</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Interventions Involving the Use of Covered Coronary Artery Stents for Pseudoaneurysms of Blalock-Taussig Shunts.</article-title>
            <source>World J Pediatr Congenit Heart Surg</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>494</fpage>
            <page-range>494-7</page-range>
            <pub-id pub-id-type="pmid">26852366</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yilmaz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Turkcan</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Ecevit</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>&#x0015e;ahan</surname>
                <given-names>Y&#x000d6;</given-names>
              </name>
              <name>
                <surname>Atalay</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Comparative Analysis of Modified BT Shunt and Central Shunt in Pediatric Patients.</article-title>
            <source>Braz J Cardiovasc Surg</source>
            <year>2024</year>
            <month>May</month>
            <day>15</day>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>e20230376</fpage>
            <pub-id pub-id-type="pmid">38748885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonnet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Petit</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Brenot</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Riou</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Angel</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Belli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baruteau</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Catheter-based interventions for modified Blalock-Taussig shunt obstruction: a 20-year experience.</article-title>
            <source>Pediatr Cardiol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>835</fpage>
            <page-range>835-41</page-range>
            <pub-id pub-id-type="pmid">25560736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marbarger</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Sandza</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Weldon</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Blalock-taussig anastomosis: the preferred shunt in infants and newborns.</article-title>
            <source>Circulation</source>
            <year>1978</year>
            <month>Sep</month>
            <volume>58</volume>
            <issue>3 Pt 2</issue>
            <fpage>I73</fpage>
            <page-range>I73-7</page-range>
            <pub-id pub-id-type="pmid">14740682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hill</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Frommelt</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Stelter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Kharouf</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Slesnick</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Saudek</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Impact of initial norwood shunt type on right ventricular deformation: the single ventricle reconstruction trial.</article-title>
            <source>J Am Soc Echocardiogr</source>
            <year>2015</year>
            <month>May</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>517</fpage>
            <page-range>517-21</page-range>
            <pub-id pub-id-type="pmid">25690998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Newburger</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Sleeper</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Gaynor</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Hollenbeck-Pringle</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Frommelt</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Mahle</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Atz</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cnota</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dunbar-Masterson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ghanayem</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Mital</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pizarro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Eckhauser</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stark</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ohye</surname>
                <given-names>RG</given-names>
              </name>
              <collab>Pediatric Heart Network Investigators</collab>
            </person-group>
            <article-title>Transplant-Free Survival and Interventions at 6 Years in the SVR Trial.</article-title>
            <source>Circulation</source>
            <year>2018</year>
            <month>May</month>
            <day>22</day>
            <volume>137</volume>
            <issue>21</issue>
            <fpage>2246</fpage>
            <page-range>2246-2253</page-range>
            <pub-id pub-id-type="pmid">29437119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marx</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Shirali</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Guey</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Cnota</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Baffa</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Border</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Colan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ensing</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Friedberg</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Idriss</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Ohye</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Saudek</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>GD</given-names>
              </name>
              <collab>Pediatric Heart Network Investigators</collab>
            </person-group>
            <article-title>Multicenter study comparing shunt type in the norwood procedure for single-ventricle lesions: three-dimensional echocardiographic analysis.</article-title>
            <source>Circ Cardiovasc Imaging</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>934</fpage>
            <page-range>934-42</page-range>
            <pub-id pub-id-type="pmid">24097422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burch</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Gerstenberger</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ravishankar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hehir</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Colan</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Sleeper</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Newburger</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Clabby</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Uzark</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Pemberton</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Pike</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Dunbar-Masterson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Khaikin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zyblewski</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Minich</surname>
                <given-names>LL</given-names>
              </name>
              <collab>Pediatric Heart Network Investigators</collab>
            </person-group>
            <article-title>Longitudinal assessment of growth in hypoplastic left heart syndrome: results from the single ventricle reconstruction trial.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2014</year>
            <month>Jun</month>
            <day>23</day>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>e000079</fpage>
            <pub-id pub-id-type="pmid">24958780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McMullan</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Permut</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Rubio</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Modified Blalock-Taussig shunt versus ductal stenting for palliation of cardiac lesions with inadequate pulmonary blood flow.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>147</volume>
            <issue>1</issue>
            <fpage>397</fpage>
            <page-range>397-401</page-range>
            <pub-id pub-id-type="pmid">24071469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157838.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bigdelian</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ghaderian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sedighi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Surgical repair of Tetralogy of Fallot following primary palliation: Right ventricular outflow track stenting versus modified Blalock-Taussig shunt.</article-title>
            <source>Indian Heart J</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>70 Suppl 3</volume>
            <issue>Suppl 3</issue>
            <fpage>S394</fpage>
            <page-range>S394-S398</page-range>
            <pub-id pub-id-type="pmid">30595296</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
